{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-25-000029","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.880928+00:00","generated_at":"2026-05-26T05:20:18.925281+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Masimo Q4 revenue $601M (+9%); Non-GAAP EPS $1.80 (+44%); FY2025 guide sees healthcare growth 8-11%","bullets":["Q4 revenue $601M (+9% YoY); Healthcare $368M (+8%), Non-healthcare $232M (+11%).","GAAP net loss per share ($6.52) due to Sound United impairment; Non-GAAP diluted EPS $1.80 (+44%).","Full-year 2024 healthcare revenue $1,395M (+9%); Non-healthcare revenue $699M (-10%).","FY2025 guidance: Healthcare revenue $1.50B-$1.53B (8-11% constant currency), Non-GAAP EPS $5.10-$5.40.","New CEO Katie Szyman cites strong healthcare momentum and record customer contracts in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-25-000029","json":"https://secwatch.observer/filing/0000937556-25-000029.json","markdown":"https://secwatch.observer/filing/0000937556-25-000029.md","text":"https://secwatch.observer/filing/0000937556-25-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/0000937556-25-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/masi-20250225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:20:18.925281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}